Composite nanoparticles for targeted inhibition of bone tumors and preparation method of composite nanoparticles
A composite nanoparticle, nanoparticle technology, applied in antitumor drugs, bone diseases, drug combinations, etc., can solve problems such as body damage and achieve the effect of repairing bone
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] The composite nanoparticles for targeting and inhibiting bone tumors include the following components in terms of mass fraction:
[0044] 3 parts of hyaluronic acid, 25 parts of tetrabutylammonium hydroxide aqueous solution, 3 parts of polyethylene glycol, 0.8 parts of dimethylaminopyridine, 3 parts of nano-hydroxyapatite, 3 parts of nitrogen carbonyl diimidazole, anhydrous dimethyl 180 parts of sulfone; the concentration of the tetrabutylammonium hydroxide aqueous solution is 40%.
Embodiment 2
[0046] The composite nanoparticles for targeting and inhibiting bone tumors include the following components in terms of mass fraction:
[0047] 4 parts of hyaluronic acid HA, 30 parts of tetrabutylammonium hydroxide aqueous solution, 4 parts of polyethylene glycol, 1 part of dimethylaminopyridine, 4 parts of nano-hydroxyapatite, 4 parts of nitrogen carbonyl diimidazole, anhydrous dimethyl Sulfone 210 parts.
Embodiment 3
[0049] The composite nanoparticles for targeting and inhibiting bone tumors include the following components in terms of mass fraction:
[0050] 5 parts of hyaluronic acid, 35 parts of tetrabutylammonium hydroxide aqueous solution, 5 parts of polyethylene glycol, 1.2 parts of dimethylaminopyridine, 5 parts of nano-hydroxyapatite, 5 parts of nitrogen carbonyl diimidazole, anhydrous dimethyl 240 parts of sulfone; the concentration of the tetrabutylammonium hydroxide aqueous solution is 40%.
[0051] The present invention provides a method for preparing composite nanoparticles targeted to inhibit bone tumors. The specific components are described in Example 2, such as figure 1 shown, including the following steps:
[0052] Step 100, preparing HA-TBA mixed product
[0053] Take 0.4g of hyaluronic acid (HA) and 3mL of 40% tetrabutylammonium hydroxide aqueous solution (TBA), mix and stir to dissolve, stir at room temperature for 30min, take Millex-HV 450nm sterile filter head to f...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



